Key details
Sponsor
Hospital Universitari Vall d'Hebron Research Institute
Collaborators
Instituto de Salud Carlos III
Enrollment target
~108 participants
Primary completion
December 2024
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years – 45 Years
Last updated October 2024